Michael Favet was appointed CEO of NeuroPace in July 2019, having previously served on their board since 2016 and as Chief Commercial Officer since 2018.
Michael Favet was appointed CEO of NeuroPace in July 2019, having previously served on their board since 2016 and as Chief Commercial Officer since 2018. Before joining NeuroPace, he was a managing director for KCK's medtech group and held senior management positions at various medical technology companies.
Full founder directory · Investor directory · Company funding database · Fundraising library